|
|
|
|
|
HOME >
CORPORATE INFO > CORPORATE ANNOUNCEMENTS
|
|
|
|
|
|
09-05-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange about Schedule of meet |
|
|
|
|
|
09-05-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
|
|
|
|
|
07-05-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding a press release dated May 07, 2024, titled "Gland Pharma receives approval for Edaravone Injection ". |
|
|
|
|
|
07-05-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding a press release dated May 07, 2024, titled "Gland Pharma receives approval for Plerixafor for Injection ". |
|
|
|
|
|
29-04-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
|
|
29-04-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange about change in Management |
|
|
|
|
|
29-04-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2024. |
|
|
|
|
|
29-04-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding a press release dated April 29, 2024, titled "Gland Pharma receives approval for Cetrorelix Acetate for Injection". |
|
|
|
|
|
10-04-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
|
|
06-04-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding a press release dated April 06, 2024, titled "Gland Pharma receives approval for Eribulin Mesylate Injection". |
|
|
|
|
|
04-04-2024
|
|
|
|
| Gland Pharma Limitedï¿‚ï¾ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
|
|
|
|
|
27-03-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
27-03-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
26-03-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding allotment of 2400 securities pursuant to ESOP/ESPS at its meeting held on March 25, 2024 |
|
|
|
|
|
26-03-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange regarding Allotment of Securities |
|
|
|
|
|
26-03-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange about Schedule of meet |
|
|
|
|
|
26-03-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
|
|
26-03-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange about change in Management |
|
|
|
|
|
26-03-2024
|
|
|
|
| Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
26-03-2024
|
|
|
|
| GLAND PHARMA LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
|
|
|
|
|
|
|